{"id":407665,"date":"2025-09-26T00:30:00","date_gmt":"2025-09-25T22:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/apolipoproteina-e-e-sintomi-neuropsichiatrici-nei-disturbi-neurocognitivi\/"},"modified":"2025-09-26T02:00:17","modified_gmt":"2025-09-26T00:00:17","slug":"apolipoproteina-e-e-sintomi-neuropsichiatrici-nei-disturbi-neurocognitivi","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/it\/apolipoproteina-e-e-sintomi-neuropsichiatrici-nei-disturbi-neurocognitivi\/","title":{"rendered":"Apolipoproteina E e sintomi neuropsichiatrici nei disturbi neurocognitivi"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>I sintomi neuropsichiatrici (NPS) come la depressione, l&#8217;ansia, l&#8217;apatia, la psicosi o i disturbi comportamentali sono tra i sintomi concomitanti pi\u00f9 comuni dei disturbi neurocognitivi e hanno un impatto sulla prognosi altrettanto forte dei deficit cognitivi. La variante genetica dell&#8217;apolipoproteina E (APOE) \u00e8 il fattore di rischio pi\u00f9 importante per la malattia di Alzheimer, ma influenza anche la comparsa di NPS in diverse malattie neurodegenerative. Una recente revisione riassume le correlazioni dimostrate tra i genotipi APOE e i sintomi neuropsichiatrici e discute la loro rilevanza clinica.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fapolipoproteina-e-e-sintomi-neuropsichiatrici-nei-disturbi-neurocognitivi%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>I sintomi neuropsichiatrici (NPS) come la depressione, l&#8217;ansia, l&#8217;apatia, la psicosi o i disturbi comportamentali sono tra i sintomi concomitanti pi\u00f9 comuni dei disturbi neurocognitivi e hanno un impatto sulla&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fapolipoproteina-e-e-sintomi-neuropsichiatrici-nei-disturbi-neurocognitivi%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":407668,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Panoramica attuale delle prove, dei meccanismi e delle implicazioni cliniche  ","footnotes":""},"category":[11519,11371,11550,11515],"tags":[84956,84955,40653],"powerkit_post_featured":[],"class_list":["post-407665","post","type-post","status-publish","format-standard","has-post-thumbnail","category-formazione-continua","category-neurologia-it","category-rx-it","category-studi","tag-apoe-it","tag-apolipoproteina-e-it","tag-nps-it","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-17 00:27:34","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"it_IT","wpml_translations":{"pt_PT":{"locale":"pt_PT","id":407658,"slug":"apolipoproteina-e-e-sintomas-neuropsiquiatricos-em-perturbacoes-neurocognitivas","post_title":"Apolipoprote\u00edna E e sintomas neuropsiqui\u00e1tricos em perturba\u00e7\u00f5es neurocognitivas","href":"https:\/\/medizinonline.com\/pt-pt\/apolipoproteina-e-e-sintomas-neuropsiquiatricos-em-perturbacoes-neurocognitivas\/"},"es_ES":{"locale":"es_ES","id":407652,"slug":"apolipoproteina-e-y-sintomas-neuropsiquiatricos-en-los-trastornos-neurocognitivos","post_title":"Apolipoprote\u00edna E y s\u00edntomas neuropsiqui\u00e1tricos en los trastornos neurocognitivos","href":"https:\/\/medizinonline.com\/es\/apolipoproteina-e-y-sintomas-neuropsiquiatricos-en-los-trastornos-neurocognitivos\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/407665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/comments?post=407665"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/407665\/revisions"}],"predecessor-version":[{"id":409321,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/407665\/revisions\/409321"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media\/407668"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media?parent=407665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/category?post=407665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/tags?post=407665"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/powerkit_post_featured?post=407665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}